Cargando…

PD-1/PD-L1 in Cancer: Pathophysiological, Diagnostic and Therapeutic Aspects

Immune evasion is a key strategy adopted by tumor cells to escape the immune system while promoting their survival and metastatic spreading. Indeed, several mechanisms have been developed by tumors to inhibit immune responses. PD-1 is a cell surface inhibitory receptor, which plays a major physiolog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Munari, Enrico, Mariotti, Francesca R., Quatrini, Linda, Bertoglio, Pietro, Tumino, Nicola, Vacca, Paola, Eccher, Albino, Ciompi, Francesco, Brunelli, Matteo, Martignoni, Guido, Bogina, Giuseppe, Moretta, Lorenzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151504/ https://www.ncbi.nlm.nih.gov/pubmed/34066087 http://dx.doi.org/10.3390/ijms22105123

Ejemplares similares

Impact of PD-L1 and PD-1 Expression on the Prognostic Significance of CD8(+) Tumor-Infiltrating Lymphocytes in Non-Small Cell Lung Cancer
por: Munari, Enrico, et al.
Publicado: (2021)

Comparison of three validated PD-L1 immunohistochemical assays in urothelial carcinoma of the bladder: interchangeability and issues related to patient selection
por: Munari, Enrico, et al.
Publicado: (2022)

The Immune Checkpoint PD-1 in Natural Killer Cells: Expression, Function and Targeting in Tumour Immunotherapy
por: Quatrini, Linda, et al.
Publicado: (2020)

Innate Lymphoid Cells: Expression of PD-1 and Other Checkpoints in Normal and Pathological Conditions
por: Mariotti, Francesca Romana, et al.
Publicado: (2019)

PD-L1 expression comparison between primary and relapsed non-small cell lung carcinoma using whole sections and clone SP263
por: Munari, Enrico, et al.
Publicado: (2018)

Presence of innate lymphoid cells in pleural effusions of primary and metastatic tumors: Functional analysis and expression of PD‐1 receptor
por: Tumino, Nicola, et al.
Publicado: (2019)

PD-L1 expression heterogeneity in non-small cell lung cancer: evaluation of small biopsies reliability
por: Munari, Enrico, et al.
Publicado: (2017)

Correction: PD-L1 expression heterogeneity in non-small cell lung cancer: evaluation of small biopsies reliability
por: Munari, Enrico, et al.
Publicado: (2018)

PD-1 in human NK cells: evidence of cytoplasmic mRNA and protein expression
por: Mariotti, Francesca R., et al.
Publicado: (2018)

Analysis of the mechanisms regulating soluble PD-1 production and function in human NK cells
por: Mariotti, Francesca Romana, et al.
Publicado: (2023)

Helper Innate Lymphoid Cells in Human Tumors: A Double-Edged Sword?
por: Tumino, Nicola, et al.
Publicado: (2020)

Atlas of PD-L1 for Pathologists: Indications, Scores, Diagnostic Platforms and Reporting Systems
por: Marletta, Stefano, et al.
Publicado: (2022)

Technical and Diagnostic Issues in Whole Slide Imaging Published Validation Studies
por: Rizzo, Paola Chiara, et al.
Publicado: (2022)

Program death ligand‐1 immunocytochemistry in lung cancer cytological samples: A systematic review
por: Satturwar, Swati, et al.
Publicado: (2022)

Inhibitory checkpoints in human natural killer cells: IUPHAR Review 28
por: Mariotti, F.R., et al.
Publicado: (2020)

PD‐L1 in oral squamous cell carcinoma: A key biomarker from the laboratory to the bedside
por: Nocini, Riccardo, et al.
Publicado: (2022)

MiT Family Translocation Renal Cell Carcinoma: from the Early Descriptions to the Current Knowledge
por: Caliò, Anna, et al.
Publicado: (2019)

Inhibitory Receptors and Checkpoints in Human NK Cells, Implications for the Immunotherapy of Cancer
por: Sivori, Simona, et al.
Publicado: (2020)

Helper Innate Lymphoid Cells in Allogenic Hematopoietic Stem Cell Transplantation and Graft Versus Host Disease
por: Quatrini, Linda, et al.
Publicado: (2020)

PD-L1–PD-1 Pathway in the Pathophysiology of Multiple Myeloma
por: Tamura, Hideto, et al.
Publicado: (2020)

Polymorphonuclear Myeloid-Derived Suppressor Cells Are Abundant in Peripheral Blood of Cancer Patients and Suppress Natural Killer Cell Anti-Tumor Activity
por: Tumino, Nicola, et al.
Publicado: (2022)

Effect of Radio-Chemotherapy on PD-L1 Immunohistochemical Expression in Head and Neck Squamous Cell Carcinoma
por: Girolami, Ilaria, et al.
Publicado: (2023)

PMN-MDSC are a new target to rescue graft-versus-leukemia activity of NK cells in haplo-HSC transplantation
por: Tumino, Nicola, et al.
Publicado: (2019)

Exploiting Human NK Cells in Tumor Therapy
por: Vacca, Paola, et al.
Publicado: (2020)

Cathepsin K: A Novel Diagnostic and Predictive Biomarker for Renal Tumors
por: Caliò, Anna, et al.
Publicado: (2021)

Characterization of Human NK Cell-Derived Exosomes: Role of DNAM1 Receptor in Exosome-Mediated Cytotoxicity against Tumor
por: Di Pace, Anna Laura, et al.
Publicado: (2020)

iPathology cockpit diagnostic station: validation according to College of American Pathologists Pathology and Laboratory Quality Center recommendation at the Hospital Trust and University of Verona
por: Brunelli, Matteo, et al.
Publicado: (2014)

Interaction Between MDSC and NK Cells in Solid and Hematological Malignancies: Impact on HSCT
por: Tumino, Nicola, et al.
Publicado: (2021)

PD/1-PD-Ls Checkpoint: Insight on the Potential Role of NK Cells
por: Pesce, Silvia, et al.
Publicado: (2019)

NK Cells and PMN-MDSCs in the Graft From G-CSF Mobilized Haploidentical Donors Display Distinct Gene Expression Profiles From Those of the Non-Mobilized Counterpart
por: Pelosi, Andrea, et al.
Publicado: (2021)

Targeting PD-1/PD-L1 interactions for cancer immunotherapy
por: Zitvogel, Laurence, et al.
Publicado: (2012)

Regulation of PD-1/PD-L1 pathway and resistance to PD-1/PD-L1 blockade
por: Bai, Jie, et al.
Publicado: (2017)

CXCR4-CXCL12-CXCR7 and PD-1/PD-L1 in Pancreatic Cancer: CXCL12 Predicts Survival of Radically Resected Patients
por: D’Alterio, Crescenzo, et al.
Publicado: (2022)

Artificial intelligence in head and neck cancer diagnosis
por: Bassani, Sara, et al.
Publicado: (2022)

Concordance between Three PD-L1 Immunohistochemical Assays in Head and Neck Squamous Cell Carcinoma (HNSCC) in a Multicenter Study
por: Guerini Rocco, Elena, et al.
Publicado: (2022)

Regulation of the Immune System Development by Glucocorticoids and Sex Hormones
por: Quatrini, Linda, et al.
Publicado: (2021)

First-line tepotinib for a very elderly patient with metastatic NSCLC harboring MET exon 14 skipping mutation and high PD-L1 expression
por: Inno, Alessandro, et al.
Publicado: (2023)

Basis of PD1/PD-L1 Therapies
por: Seliger, Barbara
Publicado: (2019)

Therapeutic PD-L1 antibodies are more effective than PD-1 antibodies in blocking PD-1/PD-L1 signaling
por: De Sousa Linhares, Annika, et al.
Publicado: (2019)

Features of Memory-Like and PD-1(+) Human NK Cell Subsets
por: Della Chiesa, Mariella, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_km9bft65jksv0sbm1ef0ij9nf9